33results about How to "Good treatment compliance" patented technology

Apparatus, systems and methods for the wireless communication of medical devices in an on-body fluid delivery system are disclosed. A system for on-body fluid delivery includes a primary patch pump adapted to attach a first infusion cannula to a user and to perform a plurality of primary patch pump functions, and a secondary patch pump adapted to attach a second infusion cannula to a user. The secondary patch pump is further adapted to perform a plurality of secondary patch pump functions substantially similar to the plurality of primary patch pump functions if an error condition associated with the primary patch pump is determined.

Apparatuses, systems and methods for the wireless communication of medical devices in a subcutaneous fluid delivery system are disclosed. A system for subcutaneous fluid delivery includes a primary patch pump adapted to attach a first infusion cannula to a user and to perform a plurality of primary patch pump functions, and a secondary patch pump adapted to attach a second infusion cannula to a user. The secondary patch pump is further adapted to perform a plurality of secondary patch pump functions substantially similar to the plurality of primary patch pump functions if an error condition associated with the primary patch pump is determined.

Apparatuses, systems and methods for the wireless communication of medical devices in a subcutaneous fluid delivery system are disclosed. A system for subcutaneous fluid delivery includes a primary patch pump adapted to attach a first infusion cannula to a user and to perform a plurality of primary patch pump functions, and a secondary patch pump adapted to attach a second infusion cannula to a user. The secondary patch pump is further adapted to perform a plurality of secondary patch pump functions substantially similar to the plurality of primary patch pump functions if an error condition associated with the primary patch pump is determined.

The invention relates to a traditional Chinese medicine composition used for treating diabetes, and a medicine composition with the traditional Chinese medicine composition used for treating diabetes. The traditional Chinese medicine composition is prepared with astragalus, rhizoma atractylodis, burdock, cortex lycii radicis, cortex mori radicis, mulberries, ramulus euonyrni, Chinese lobelia, rhizoma anemarrhenae, ginseng, Chinese yams and polygonatum canaliculatum as raw material medicine. The traditional Chinese medicine composition is small in toxic and side effect, obvious in curative effect, simple in production process, low in production cost, capable of being easily and industrially produced on a large scale and convenient to take, and has the high medicine stability.

The invention relates to a traditional Chinese medicine for treating alcoholic liver damage. , tangerine peel, and divine music as raw materials, the composition and weight ratio of raw materials are: Pueraria 30‑90, Pueraria 20‑60, Polygonum cuspidatum 20‑50, Yin Chen 15‑30, Codonopsis 15‑30, Atractylodes macrocephala 15‑30, Salvia miltiorrhiza 20‑ 50. Loofah 10‑20, Lycium barbarum 15‑30, Cornus 15‑30, Amomum 10‑15, Bai Keren 15‑20, Alisma 15‑30, Poria 15‑30, Chenpi 10‑20, Divine Comedy 15 -30. The invention adopts traditional pure Chinese medicine, takes pills as dosage form, and takes it with boiled water, and can effectively treat alcoholic liver damage diseases, including abnormal liver function, fatty liver changes and other diseases. The selected traditional Chinese medicine compatibility formula is reasonable, and the therapeutic effect is remarkable. It has no obvious toxic side effects and adverse reactions, is cheap, and has good treatment compliance.

The application discloses a composition comprising: 5-methyltetrahydrofolate and \or its pharmaceutically acceptable salt; betaine and \or its pharmaceutically acceptable salt; and vortixi Ting and \or its pharmaceutically acceptable salt. The composition is used for the treatment of cognitive impairment of senile depression, and compared with vortioxetine alone and 5-methyltetrahydrofolate and betaine combination, it can synergize and complement each other, shorten the treatment cycle, improve Clinical safety and treatment compliance, easy to promote and apply.

The invention discloses a Chinese prepared medicine for curing cervical spondylosis and a preparation method thereof. The Chinese prepared medicine comprises the raw materials of Chinese medicines with the following mixture ratio by weight: 15 to 30 portions of honeysuckle, 10 to 20 portions of fructus forsythiae, 9 to 15 portions of ophiopogon root, 15 to 40 portions of radix astragali, 15 to 30portions of red sage root, 10 to 20 portions of rhizoma corydalis, 10 to 15 portions of rhizoma gastrodiae and 10 to 20 portions of rhizoma ligustici wallichii. The preparation method of the Chinese prepared medicine includes the steps that all the raw materials of Chinese medicines are prepared according to the prescription to be jointly crushed into fine powder with more than 100 meshes; the obtained fine powder is evenly mixed and treated with ozone sterilization for 20 minutes to be then prepared into capsules or added with honey to be then evenly stirred and processed into pills. The Chinese prepared medicine of the invention can clear away heat and toxic materials, reduce the inflammatory exudation, inhibit leukocyte migration, activate blood circulation to dissipate blood stasis, unclog the meridian, reduce swelling and ease pain, especially has remarkable curative effect to patient with cervical spondylosis with a short period of treatment, and find no obvious side effects in the treatment course and has good treatment compliance of patients. In addition, the Chinese prepared medicine of the invention is a preparation of pure Chinese herbs and an effective drug for curing the cervical spondylosis related to throat infection.

The invention relates to traditional Chinese medicine for treating chronic gastritis and a peptic ulcer disease caused by helicobacter pylori infection. The traditional Chinese medicine is composed of the following raw materials, by weight, 10-15 parts of mangnolia officinalis, 15-20 parts of astragalus, 25-30 parts of salvia miltiorrhiza, 25-30 parts of dandelion, 15-20 parts of oldenlandia diffusa, 10-25 parts of tangerine peels, 10-15 parts of white paeony roots, 10-15 parts of radix angelicae, 10-15 parts of rhizoma atractylodis, 15-20 parts of rhizoma bletillae and 25-30 parts of cuttle bones. The traditional Chinese medicine is reasonable in composition, obvious in treatment effect, good in improvement effect on gastric mucosa observed under an endoscope, obvious in improvement effect on stomach pathology change, high in eradication rate of stomach helicobacter pylori, free of obvious toxic and side effect and adverse reaction, good in treatment compliance and capable of effectively treating helicobacter pylori and stomach diseases related to the same.

The invention provides a Chinese patent medicine preparation for curing the depression after cerebral infarction. The invention comprises the drugs calculated according to the proportion by weight as follows: 10 to 20 parts of rhizome of Sichuan lovage, 6 to 10 parts of bupleurum root, 6 to 15 parts of polygala root, 10 to 20 parts of Chinese angelica root, 10 to 30 parts of root of herbaceous peony, 10 to 15 parts of curcuma root, 10 to 20 parts of safflower, 15 to 25 parts of arboruitae seed and 30 to 50 parts of parched wild jujube seed. The Chinese patent medicine preparation adopts the preparation method that the Chinese drug materials are ground into fine powder of more than 100 meshes according to the formulation, and are uniformly mixed, the ozone sterilization processing is performed for 20 minutes, the materials are mixed with honey and stirred uniformly, and then is processed into pill dosage form or capsule dosage form. The preparation is a pure herbal preparation, and hasthe advantages that the curative effect is remarkable, the production method is simple, the cost is low, the toxic and side effects are less, the preparation is easy to be accepted by the patient, the drugs are mutually combined and has the functions of dispersing and rectifying the depressed liver-energy, stimulating circulation to end stasis, eliminating sputum, inducing resuscitation, waking up the patient from inconsciousness and allaying restlessness, the preparation can be used for curing the depression after cerebral infarction with remarkable curative effect and no obvious toxic and side effects.

The invention discloses an idiopathic thrombocytopenic purpura medicament composition. The medicament composition is prepared by active pharmaceutical ingredients including, by weight, 100-200 parts of Gynura segetum, 50-150 parts of forsythia, 100-200 parts of field thistle, 100-200 parts of rehmannia, 10-100 parts of fried gardenia, 50-100 parts of savatier monochasma and 50-150 parts of fried yams. A preparation method of the idiopathic thrombocytopenic purpura medicament composition includes steps of weighting the active pharmaceutical ingredients according to the formulas, evenly mixing the active pharmaceutical ingredients by grinding, extracting water and concentrating or the combination of the both, and then obtaining the medicament composition. The medicament composition is capable of cooling blood and stopping blood, clearing heat and removing toxicity, and is used for various hemorrhages caused by the heat forced blood line and the blood overflowing outside pulse such as bleeding gums, blood oozing out of nasals, skin purpura, hemafecia, hematuria and menorrhagia .